Recent developments in colorectal cancer

Journal of the Royal College of Physicians of London

Volumn 31, Issue 5, 1997, Pages 483-487

  Lance, Peter ^a  

^a BUFFALO GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NONSTEROID ANTIINFLAMMATORY AGENT;

ADENOCARCINOMA; COLON POLYPOSIS; COLORECTAL TUMOR; GENETICS; HUMAN; MASS SCREENING; MIDDLE AGED; PATHOLOGY; REVIEW;

ADENOCARCINOMA; ADENOMATOUS POLYPOSIS COLI; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; COLORECTAL NEOPLASMS; COLORECTAL NEOPLASMS, HEREDITARY NONPOLYPOSIS; HUMANS; MASS SCREENING; MIDDLE AGED;

EID: 0031217307     PISSN: 00358819     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Winawer SJ, Fletcher RH, Miller L, Godlee F, et al. Colorectal cancer screening: clinical guidelines and rationale. Gastroenterology 1997;112:594-642.
2. Itzkowitz SH. Inflammatory bowel disease and cancer. Gastroenterol Clin North Am 1997;26:129-39.
3. Kinzler KW, Vogelstein B. Lessons from hereditary colorectal cancer. Cell 1996;87:159-70.
4. Bodmer WF. The somatic evolution of cancer. J Roy Coll Physicians Lond 1997;31:82-9.
5. Huang J, Papadopoulos N, McKinley AJ, Farrington SM, et al. APC mutations in colorectal tumours with mismatch repair deficiency. Proc Natl Acad Sci USA 1996;93:9049-54.
6. Burt RW. Familial risk and colorectal cancer. Gastroenterol Clin North Am 1996;25:793-803.
7. Atkin WS, Cuzick J, Northover JMA, Whynes DK. Prevention of colorectal cancer by once-only sigmoidoscopy. Lancet 1993;341:736-40.
8. Kim EC, Lance P. Colorectal polyps and their relationship to cancer. Gastroenterol Clin North Am 1997;26:1-17.
9. Hardcastle JD, Chamberlain JO, Robinson MHE, Moss SM, et al. Randomised controlled trial of faecal-occult-blood screening for colorectal cancer. Lancet 1996;348:1472-7.
10. Mandel JS, Bond JH, Church TR, Shover DG, et al. Reducing mortality from colorectal cancer by screening for fecal occult blood. N Engl J Med 1993; 328:1365-71.
11. Ahlquist DA, Wieand HS, Moertel CG, McGill DB, et al. Accuracy of fecal occult blood screening for colorectal neoplasia. JAMA 1993;269:1262-7.
12. Selby JV, Friedman GD, Quesenberry CP, Weiss NS. A case-control study of screening sigmoidoscopy and mortality from colorectal cancer. N Engl J Med 1992;326:653-7.
13. Zarchy TM, Ershoff D. Do characteristics of adenomas on flexible sigmoidoscopy predict advanced lesions on baseline colonoscopy? Gastroenterology 1994; 106:1501-4.
14. Read TE, Read JD, Butterly LF. Importance of adenomas 5 mm or less in diameter that are detected by sigmoidoscopy. N Engl J Med 1997;336:8-12.
15. Marshall JR, Fay D, Lance P. Potential costs of flexible sigmoidoscopy-based colorectal cancer screening. Gastroenterology 1996;111:1411-7.
16. Eckhauser FE, Knol JA. Surgery for primary and metastatic colorectal cancer. Gastroenterol Clin North Am 1997;26:103-28.
17. Slevin ML. Adjuvant treatment for colorectal cancer: no more room for nihilism. Br Med J 1996;312:392-3.
18. Minsky BD. Adjuvant therapy for rectal cancer - a good first step. N Engl J Med 1997;336:1016-7.
19. DuBois RN, Giardiello FM, Smalley WE. NSAIDs, eicosanoids, and colorectal cancer prevention. Gastroenterol Clin North Am 1996;25:773-91.